INT170939
From wiki-pain
|
|
|
|
|
Sentences Mentioned In
Key: | Protein | Mutation | Event | Anatomy | Negation | Speculation | Pain term | Disease term |
However, the rate of increase of LPO in case of AT + smoked animals were comparatively less. | |||||||||||||||
| |||||||||||||||
|
However, AT appears to be responsible for the retarded increase of LPO in the AT + smoked group with increase in the duration of smoking. | |||||||||||||||
| |||||||||||||||
|
As the exposure of CS to the mice was extended from 2 to 4, 6 and 8 weeks, a significant increase in the LPO levels was observed. | |||||||||||||||
| |||||||||||||||
|
The level of LPO after a single ip dose (10 mg/kg) was increased in as short a time as 1 hr (although not significantly) and persisted for up to 28 days. | |||||||||||||||
| |||||||||||||||
|
Multiple doses of PQ significantly increased the level of LPO in each region (region ANOVAs: VM, F3,12 = 9.9, p = 0.001; STR, F3,12 =17.9, p < 0.0001; FCtx, F3,12 = 3.8, p = 0.04) when measured after 1 week compared with saline. | |||||||||||||||
| |||||||||||||||
|
However, the extent of the increase in the pulmonary LPO levels in the AT + smoked group was comparatively low as compared to the animals not fed with AT and only exposed to CS. | |||||||||||||||
| |||||||||||||||
|
Therefore, the depletion of GSH seems to be associated with the increase of LPO. | |||||||||||||||
| |||||||||||||||
|
It seems that the treatment of CS inhalation for 2 weeks was not enough to pose any significant oxidative stress and thereby no increase in LPO. | |||||||||||||||
| |||||||||||||||
|
Interestingly, repeated dosing did not result in an increase in the amount of LPO (Figure 4B). | |||||||||||||||
| |||||||||||||||
|
Younes and Siegers [11] have also observed that depletion of GSH enhances LPO. | |||||||||||||||
| |||||||||||||||
|
However, the extent of increase in LPO levels due to CS exposure for 4, 6 or 8 weeks in the mice treated with AT was comparatively less. | |||||||||||||||
| |||||||||||||||
|
It was also observed that as the exposure to CS was extended from 4 to 6 and then to 8 weeks, there was a corresponding increase in the pulmonary LPO levels in both, the smoked as well as the AT + smoked group. | |||||||||||||||
| |||||||||||||||
|
In our studies, a significant decrease in the GSH levels was observed in both the smoked as well as AT + smoked groups and concomitantly there was an increase in the LPO levels. | |||||||||||||||
| |||||||||||||||
|
There was a gradual increase in the LPO levels as the extent of CS inhalation increased from 4 to 8 weeks. | |||||||||||||||
| |||||||||||||||
|
However, the extent of increase in LPO levels was comparatively less in the AT + smoked group. | |||||||||||||||
| |||||||||||||||
|
Despite the cumulative tissue levels of PQ after one, three, and five doses, the level of LPO was not further increased. | |||||||||||||||
| |||||||||||||||
|
An elevated level of LPO was still present in VM after 28 days. | |||||||||||||||
| |||||||||||||||
|
In this phase of study it was observed that CS inhalation triggered LPO both in smoked and AT + smoked group. | |||||||||||||||
| |||||||||||||||
|
The level of tissue lipid peroxides (LPO) was differentially elevated in three regions, being highest in VM, lower in striatum (STR), and least in frontal cortex (FCtx), with the earliest significant elevation detected at 1 day. | |||||||||||||||
| |||||||||||||||
|
General Comments
This test has worked.